CRP Exemption Timeframes, Confidentiality Safeguards Addressed By CHPA
This article was originally published in The Tan Sheet
Executive Summary
OTC drug companies need substantial preparation time as well as ensured confidentiality when submitting child-resistant packaging exemption requests, CHPA stresses in recent comments to the Consumer Product Safety Commission.
You may also be interested in...
CPSC Rx-To-OTC Switch Final Rule Published As Gall Loses Chair Nomination
Manufacturers cannot be ensured confidentiality when submitting child-resistant packaging (CRP) exemption requests for oral Rx-to-OTC switches, the Consumer Product Safety Commission clarifies in its final rule requiring CRP for all such drugs.
New Use/New Dose OTCs Subject To CR Packaging Under CPSC Rule
Child-resistant packaging would be required for new dosages and new forms of Rx-to-OTC switch drugs, regardless of previous Rx status, under new regulations proposed by the Consumer Product Safety Commission.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC